MarketPeel
Insider Trading Intelligence
Pricing
…
IM

Ian Mortimer

XENE
PRESIDENT & CEO · XENON PHARMACEUTICALS INC. · CIK 0001619961
FILING MIX · LIFETIME38%/62%
BUYS
26
SELLS
42
TOTAL VALUE
$29.30M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
19,923
AVG SELL PX
$53.02
TRADE KIND
SHOWING 68 / 68
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
25 backtested trades · 8 horizons · 51 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Ian Mortimer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d25+84.00%-6.55%-0.39%-6.16%-7.98%—
14d25+76.00%-5.91%-1.02%-4.89%-3.13%—
30d25+92.00%-4.68%+0.86%-5.55%-7.98%—
60d25+96.00%-8.10%+4.50%-12.60%-15.80%—
90d25+76.00%-3.18%+2.96%-6.14%-14.25%—
180d25(11 pending)+50.00%+0.17%+7.01%-9.88%-25.82%—
1y25(18 pending)+42.86%-0.14%+21.32%-21.46%-10.70%—
2y25(22 pending)+100.00%-28.14%+44.73%-72.87%-72.87%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XENE · 19,923 shares · as of Mar 13, 2026
0100,000200,000300,000400,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 26 buys / 42 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
7,308$55.23$403.6K19,923Mar 13, 2026Mar 13, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
12,500——27,231Mar 12, 2026Mar 13, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
12,500——37,500Mar 12, 2026Mar 13, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
11,269$60.11$677.4K14,731Mar 10, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
31,694$59.88$1.90M27,515Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
21,791$58.81$1.28M59,209Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
75,000$8.40$630.0K81,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
20,000——0Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
65,000$9.44$613.6K71,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
12,479$59.50$742.5K18,521Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
65,000——0Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
25,000——0Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
75,000——0Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
105,000——0Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
20,000——26,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
2,449$61.26$150.0K6,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,000——20,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
25,000$3.10$77.5K31,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
21,515$60.49$1.30M6,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
43,348$59.26$2.57M72,652Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
61,652$60.08$3.70M6,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
65,000$62.06$4.03M6,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
10,072$60.47$609.1K8,449Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
105,000$4.75$498.8K111,000Mar 9, 2026Mar 11, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
65,000——65,000Jan 9, 2026Jan 9, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
350,000——350,000Jan 9, 2026Jan 9, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
37,938$44.40$1.68M8,062Jan 2, 2026Jan 2, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
2,062$44.93$92.6K6,000Jan 2, 2026Jan 2, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
40,000$7.49$299.6K46,000Jan 2, 2026Jan 2, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
40,000——0Jan 2, 2026Jan 2, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
8,820$45.59$402.1K8,010Dec 8, 2025Dec 9, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
2,010$46.32$93.1K6,000Dec 8, 2025Dec 9, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
14,375$45.03$647.3K16,830Dec 5, 2025Dec 9, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
97$45.01$4.4K31,205Nov 28, 2025Dec 3, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT, CEO & INTERIM CFO
25,000$7.69$192.3K56,302Oct 1, 2025Oct 1, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
25,000$40.16$1.00M31,302Oct 1, 2025Oct 1, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT, CEO & INTERIM CFO
25,000——0Oct 1, 2025Oct 1, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
275,000——275,000Mar 12, 2025Mar 13, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
50,000——50,000Mar 12, 2025Mar 13, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,149$41.07$47.2K31,302Jan 27, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
15,166$40.46$613.6K31,302Jan 27, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
16,315——0Jan 27, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
1,149$17.76$20.4K32,451Jan 27, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
15,166$17.76$269.3K46,468Jan 27, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
22,468$17.76$399.0K53,770Jan 24, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
22,468——16,315Jan 24, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
22,468$40.20$903.2K31,302Jan 24, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
16,217$40.08$650.0K31,302Jan 23, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
16,217$17.76$288.0K47,519Jan 23, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
16,217——38,783Jan 23, 2025Jan 27, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
250,000——250,000Mar 11, 2024Mar 12, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
13,179$41.37$545.2K27,708May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
1,407$41.49$58.4K31,302May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
42,592——0May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
42,592$9.44$402.1K48,592May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
1,171$41.84$49.0K32,709May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
7,310$41.84$305.9K41,282May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
20,576——0May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
3,902$41.84$163.3K40,887May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
6,172——0May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
20,576$9.85$202.7K44,789May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
PRESIDENT & CEO
6,172$9.85$60.8K33,880May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
PRESIDENT & CEO
17,069$41.44$707.3K24,213May 24, 2023May 26, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
380,000——380,000Mar 10, 2023Mar 14, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
400,000——400,000Mar 10, 2022Mar 14, 2022 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
125,000——125,000Jun 3, 2021Jun 3, 2021 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
100,000——100,000Mar 12, 2021Mar 15, 2021 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
145,000——145,000Mar 12, 2020Mar 13, 2020 ↗View →
Other insiders · XENE
Loading peer insiders…
About this filer
CIK 0001619961
ROLE
PRESIDENT & CEO
PRIMARY
XENE
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001619961DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback